Core Viewpoint - The article compares The Cooper Companies (COO) and West Pharmaceutical Services (WST) to determine which stock is more attractive to value investors [1] Group 1: Zacks Rank and Earnings Outlook - Both COO and WST currently have a Zacks Rank of 2 (Buy), indicating a positive earnings outlook due to favorable analyst estimate revisions [3] - The Zacks Rank is a strategy that targets companies with positive earnings estimate revision trends, which is beneficial for investors [2] Group 2: Valuation Metrics - COO has a forward P/E ratio of 17.91, while WST has a forward P/E of 31.34, suggesting COO is more attractively priced [5] - COO's PEG ratio is 2.30, compared to WST's PEG ratio of 3.31, indicating that COO may offer better value relative to its expected earnings growth [5] - COO has a P/B ratio of 1.95, while WST has a P/B of 5.67, further supporting the notion that COO is undervalued compared to WST [6] Group 3: Value Grades - Based on various valuation metrics, COO holds a Value grade of B, while WST has a Value grade of C, indicating that COO is the superior value option at this time [6]
COO vs. WST: Which Stock Should Value Investors Buy Now?